The Board has granted a 100% disability rating for the Veteran's myeloproliferative disorder, including myelofibrosis and myeloid leukemia, finding that his condition equated with symptoms requiring peripheral blood or bone marrow stem cell transplant, or continuous myelosuppressive or immunosuppressive therapy treatment.
The deciding factor: The Veteran's overall disability picture equated with symptoms requiring peripheral blood or bone marrow stem cell transplant, or continuous myelosuppressive or immunosuppressive therapy treatment.
- Claimed conditions
- myeloproliferative disorder, myelofibrosis, myeloid leukemia
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating assigned
- 100%
- Decision date
- May 29, 2024
- Citation
- A24027856
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Look up the original decision on VA.gov (opens in a new tab) using citation A24027856.
What this means for you
A grant means the Board agreed the veteran was entitled to the benefit. Decisions like this show the kind of evidence and arguments that tend to succeed for claims like it.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Remanded (sent back)
The Veteran's claims for service connection for myeloproliferative disorder and thrombocytopenia, related to in-service radiation exposure during Operation Tomodachi, are being remanded due to the need for a VA examination. The issues of entitlement to a temporary total disability rating due to hospitalization or treatment for a service-connected condition requiring convalescence are also being remanded as they are inextricably intertwined with the service connection claims.
- Remanded (sent back)
The Veteran's claims for service connection of hypertension, migraines, and myeloproliferative disorder are being remanded due to a duty to assist error in obtaining private treatment records. The Board will consider the evidence again after acquiring these records.
- Dismissed
The Board dismissed the appeal as the proposed severance of service connection for prostate cancer and myelofibrosis was not a final decision, and thus premature.
- Granted
The Board has determined that the Veteran's myelofibrosis, which was related to in-service herbicide exposure (Agent Orange), caused his death. Therefore, service connection for cause of death is granted.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.